本页面由Tiger Trade Technology Pte. Ltd.提供服务

Crescent Biopharma Inc

12.91
-1.5500-10.72%
盘后:12.910.00000.00%19:30 EDT
成交量:19.71万
成交额:263.27万
市值:4.80亿
市盈率:-1.74
高:14.67
开:14.46
低:12.85
收:14.46
52周最高:27.41
52周最低:8.72
股本:3,714.39万
流通股本:1,595.35万
量比:0.42
换手率:1.24%
股息:- -
股息率:- -
每股收益(TTM):-7.4105
每股收益(LYR):-12.8150
净资产收益率:-160.75%
总资产收益率:-69.15%
市净率:6.61
市盈率(LYR):-1.01

数据加载中...

2019/08/29

重要事件披露

Current report, items 5.02 and 9.01
2019/08/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/01

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/01

重要事件披露

Current report, items 2.02 and 9.01
2019/07/24

超过5%披露

General statement of acquisition of beneficial ownership
2019/07/23

超过5%披露

General statement of acquisition of beneficial ownership
2019/07/15

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/07/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/07/02

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/02

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/02

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/02

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/17

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/17

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/17

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/17

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/17

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/17

重要事件披露

Current report, item 5.07
2019/05/02

季度报告

Quarterly report [Sections 13 or 15(d)]